These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antenatal screening for Down's syndrome with the quadruple test. Wald NJ; Huttly WJ; Hackshaw AK Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052 [TBL] [Abstract][Full Text] [Related]
8. Prenatal reflex DNA screening for Down syndrome: enhancing the screening performance of the initial first trimester test. Wald NJ; Bestwick JP Prenat Diagn; 2016 Apr; 36(4):328-31. PubMed ID: 26841247 [TBL] [Abstract][Full Text] [Related]
9. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology. Hu H; Jiang Y; Zhang M; Liu S; Hao N; Zhou J; Liu J; Zhang X; Ma L Exp Biol Med (Maywood); 2017 Mar; 242(5):547-553. PubMed ID: 28056555 [TBL] [Abstract][Full Text] [Related]
10. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. Wald NJ; Watt HC; Hackshaw AK N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601 [TBL] [Abstract][Full Text] [Related]
12. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome. Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976 [TBL] [Abstract][Full Text] [Related]
13. Fewer women aged 35 and older choose serum screening for Down's syndrome: Impact and implications. Lambert-Messerlian G; Palomaki GE J Med Screen; 2019 Jun; 26(2):59-66. PubMed ID: 30253677 [TBL] [Abstract][Full Text] [Related]
14. Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13. Bestwick JP; Wald NJ PLoS One; 2019; 14(7):e0220053. PubMed ID: 31344071 [TBL] [Abstract][Full Text] [Related]
15. Sequential integrated antenatal screening for Down's syndrome, trisomy 18 and trisomy 13. Bestwick JP; Wald NJ J Med Screen; 2016 Sep; 23(3):116-23. PubMed ID: 26498068 [TBL] [Abstract][Full Text] [Related]
16. Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests. Borrell A; Borobio V; Bestwick JP; Wald NJ J Med Screen; 2009; 16(3):112-8. PubMed ID: 19805751 [TBL] [Abstract][Full Text] [Related]
17. Validation plots in antenatal screening for Down's syndrome. Wald NJ; Bestwick JP; Huttly WJ; Morris JK; George LM J Med Screen; 2006; 13(4):166-71. PubMed ID: 17217604 [TBL] [Abstract][Full Text] [Related]
18. Introduction of first trimester combined test increases uptake of Down's syndrome screening. Tringham GM; Nawaz TS; Holding S; Mcfarlane J; Lindow SW Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):95-8. PubMed ID: 21839574 [TBL] [Abstract][Full Text] [Related]
19. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869 [TBL] [Abstract][Full Text] [Related]
20. Improvements in antenatal screening for Down's syndrome. Wald NJ; Bestwick JP; Huttly WJ J Med Screen; 2013 Mar; 20(1):7-14. PubMed ID: 23512549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]